Spyre Therapeutics, Inc. (SYRE)

33.62 -0.74 (-2.15%) USD  |  NASDAQ  |  Dec 12, 16:00
33.79 +0.17 (+0.51%) After-Hours: 20:00
More

Spyre Therapeutics EPS Diluted (TTM): -2.178 for Sept. 30, 2025

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
PTC Therapeutics, Inc. 8.556
NovaBay Pharmaceuticals, Inc. 0.5953
Palatin Technologies, Inc. -4.241
Theriva Biologics, Inc. -5.537
Oragenics, Inc. -13.18